Oppenheimer Asset Management’s Insmed INSM Stock Holding History

Oppenheimer Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.71M	Buy	16,061 +1,336	+9%	+$162K	0.02%	624
2026 Q1	$2.41M	Buy	14,725 +1,574	+12%	+$242K	0.03%	501
2025 Q4	$2.29M	Sell	13,151 -2,702	-17%	-$493K	0.03%	478
2025 Q3	$2.28M	Sell	15,853 -5,521	-26%	-$676K	0.03%	531
2025 Q2	$2.15M	Buy	21,374 +1,439	+7%	+$110K	0.02%	531
2025 Q1	$1.52M	Buy	19,935 +5,453	+38%	+$417K	0.02%	608
2024 Q4	$1,000K	Buy	14,482 +33	+0.2%	+$2.38K	0.01%	716
2024 Q3	$1.05M	Buy	14,449 +7,751	+116%	+$572K	0.01%	712
2024 Q2	$449K	Buy	+6,698	New	+$260K	0.01%	884

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Oppenheimer Asset Management's INSM Position: Q2 2026 in Review

Oppenheimer Asset Management increased its Insmed (INSM) stake by 9.1% in Q2 2026, buying an estimated $162K and bringing the position to 16,061 shares worth $1.71M. The position accounts for 0.02% of the portfolio, ranked #624.

Oppenheimer Asset Management first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.41M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Oppenheimer Asset Management held 16,061 shares of Insmed worth $1.71M as of Q2 2026.
Oppenheimer Asset Management bought 1,336 Insmed shares in Q2 2026, an estimated $162K.
Insmed made up 0.02% of Oppenheimer Asset Management's portfolio in Q2 2026, its #624 holding.
Oppenheimer Asset Management first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
Oppenheimer Asset Management's Insmed position peaked at $2.41M in Q1 2026.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.